Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 11/20 | 0.37 |
| ▸ | MEN1 | O00255 | 11/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.31 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.31 |
| ▸ | ITGAV | P06756 | 1/20 | 0.31 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | HBB | P68871 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18084352 | 0.79 | POLB (0.35) | ALDH1A1POLB | |
| SCHEMBL2238550 | 0.75 | POLB (0.38) | POLB | |
| SCHEMBL12562612 | 0.75 | MEN1 (0.44) | MAPTMEN1KMT2ARAB9AL3MBTL1 | |
| SCHEMBL2239215 | 0.72 | TSHR (0.38) | ALDH1A1POLB | |
| SCHEMBL18510166 | 0.70 | GLA (0.41) | KMT2AALDH1A1POLB | |
| SCHEMBL30779753 | 0.70 | GLA (0.41) | KMT2AALDH1A1POLB | |
| SCHEMBL30699 | 0.70 | GLA (0.41) | KMT2AALDH1A1POLB | |
| SCHEMBL2237709 | 0.69 | — | — | |
| SCHEMBL2237489 | 0.69 | CRBN (0.32) | CRBN | |
| Water SCHEMBL20427405 | 0.69 | GLA (0.40) | KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114423407-A | Kit and method for dyeing keratin materials with an aminosilicone and a colouring compound | 汉高股份有限及两合公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-113616661-A | Neuroactive steroids, compositions and uses thereof | 萨奇治疗股份有限公司 | 2021-11-09 | — | — | CN | disclosed |
| CN-112789354-A | Process for producing acetic acid complementary alkyl ester compounds | 弗门尼舍有限公司 | 2021-05-11 | — | — | CN | disclosed |
| CN-107708647-B | Medical bathing equipment | BSN医疗有限公司 | 2021-02-19 | — | — | CN | disclosed |
| US-7994330-B2 | Oxidizing p-xylene to terephthalic acid using a catalyst having a dicarboximide skeleton; hydrothermally treating the product with hot water, decomposing and removing catalyst impurities | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-7524986-B2 | Methods for producing aromatic carboxylic acids | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20080171881-A1 | Method for Producing Organic Compound and Method for Decomposing Compound Having Dicarboximide Skeleton | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2008-07-17 | — | — | US | disclosed |
| EP-1870394-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND METHOD FOR DECOMPOSING COMPOUND HAVING DICARBOXYIMIDE SKELETON | Daicel Chemical Industries, Ltd. (JP) | 2007-12-26 | — | — | EP | disclosed |
| US-7288649-B2 | Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-10-30 | — | — | US | disclosed |
| US-20070191634-A1 | Methods for producing aromatic carboxylic acids | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1342715-B1 | Process for producing oximes using nitirites | DAICEL CHEM (JP) | 2006-09-13 | — | — | EP | disclosed |
| US-7091342-B2 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-15 | — | — | US | disclosed |
| US-20060030716-A1 | Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst | ISHII YASUTAKA | 2006-02-09 | — | — | US | disclosed |
| US-20050020439-A1 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2005-01-27 | — | — | US | disclosed |
| EP-1459804-A1 | CATALYSTS COMPRISING CYCLIC ACYLUREA COMPOUNDS AND PROCESSES FOR PRODUCTION OF ORGANIC COMPOUNDS WITH THE SAME | Daicel Chemical Industries, Ltd. (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-6768023-B2 | REACTING AN ESTER OR SALT OF NITROUS ACID WITH A COMPOUND THAT GENERATES A FREE RADICAL IN THE PRESENCE OF A NITROGEN CONTAINING CYCLIC COMPOUND CONTAINING AN N-OXY OR -HYDROXY IMIDE GROUP; FORMING OXIMES, NITRO COMPOUNDS, AND KETONES | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-07-27 | — | — | US | disclosed |
| CN-1152866-C | Benzimidazoles, production thereof and use thereof medicaments | ���ָ��Ӣ��ķ�������Ϲ�˾ | 2004-06-09 | — | — | CN | disclosed |
| US-20030171618-A1 | Process for producing organic compounds using nitrites | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-09-11 | — | — | US | disclosed |
| EP-1342715-A2 | Process for producing oximes using nitirites | Daicel Chemical Industries, Ltd. (JP) | 2003-09-10 | — | — | EP | disclosed |
| CN-1308614-A | Benzimidazoles, production thereof and use thereof medicaments | BOEHRINGER INGELHEIM PHAMA KG (DE) | 2001-08-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171618-A1 | Process for producing organic compounds using nitrites | NOS1, NOS2, NOS3 | MAPT 3597/4885MEN1 1755/4885KMT2A 3719/4885 |
| US-20080171881-A1 | Method for Producing Organic Compound and Method for Decomposing Compound Having Dicarboximide Skeleton | DHPS, OGDH, MCCC2 | MAPT 1073/4885MEN1 1887/4885KMT2A 1455/4885 |
| US-20070191634-A1 | Methods for producing aromatic carboxylic acids | PAH, AHR, HAO2 | MAPT 3821/4885MEN1 4514/4885KMT2A 1551/4885 |
| US-20060030716-A1 | Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst | MOGAT2, HAT1, ACOX1 | MAPT 4873/4885MEN1 1255/4885KMT2A 1306/4885 |
| US-20050020439-A1 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | MOGAT2, ACSS2, ACOX1 | MAPT 4871/4885MEN1 1259/4885KMT2A 1623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.